136 related articles for article (PubMed ID: 19470245)
21. Jun activation domain-binding protein 1 is required for mitotic checkpoint activation via its involvement in hyperphosphorylation of 53BP1.
Kwak HJ; Kim SH; Yoo HG; Park SH; Lee CH
J Cancer Res Clin Oncol; 2005 Dec; 131(12):789-96. PubMed ID: 16187115
[TBL] [Abstract][Full Text] [Related]
22. Jab1/CSN5 induces the cytoplasmic localization and degradation of RUNX3.
Kim JH; Choi JK; Cinghu S; Jang JW; Lee YS; Li YH; Goh YM; Chi XZ; Lee KS; Wee H; Bae SC
J Cell Biochem; 2009 Jun; 107(3):557-65. PubMed ID: 19350572
[TBL] [Abstract][Full Text] [Related]
23. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells.
Hsu MC; Chang HC; Hung WC
Endocr Relat Cancer; 2007 Sep; 14(3):655-67. PubMed ID: 17914096
[TBL] [Abstract][Full Text] [Related]
24. Physical interaction of Jab1 with human serotonin 6 G-protein-coupled receptor and their possible roles in cell survival.
Yun HM; Baik JH; Kang I; Jin C; Rhim H
J Biol Chem; 2010 Mar; 285(13):10016-10029. PubMed ID: 20093369
[TBL] [Abstract][Full Text] [Related]
25. Jab1 interacts directly with HIF-1alpha and regulates its stability.
Bae MK; Ahn MY; Jeong JW; Bae MH; Lee YM; Bae SK; Park JW; Kim KR; Kim KW
J Biol Chem; 2002 Jan; 277(1):9-12. PubMed ID: 11707426
[TBL] [Abstract][Full Text] [Related]
26. Depletion of Jab1 inhibits proliferation of pancreatic cancer cell lines.
Fukumoto A; Tomoda K; Yoneda-Kato N; Nakajima Y; Kato JY
FEBS Lett; 2006 Oct; 580(25):5836-44. PubMed ID: 17027978
[TBL] [Abstract][Full Text] [Related]
27. Targeted inactivation of the COP9 signalosome impairs multiple stages of T cell development.
Panattoni M; Sanvito F; Basso V; Doglioni C; Casorati G; Montini E; Bender JR; Mondino A; Pardi R
J Exp Med; 2008 Feb; 205(2):465-77. PubMed ID: 18268034
[TBL] [Abstract][Full Text] [Related]
28. Roles for CSN5 in control of p53/MDM2 activities.
Zhang XC; Chen J; Su CH; Yang HY; Lee MH
J Cell Biochem; 2008 Mar; 103(4):1219-30. PubMed ID: 17879958
[TBL] [Abstract][Full Text] [Related]
29. Jun activation domain-binding protein 1 negatively regulate p27 kip1 in non-Hodgkin's lymphomas.
Wang Y; Fei M; Cheng C; Zhang D; Lu J; He S; Zhao Y; Wang Y; Shen A
Cancer Biol Ther; 2008 Mar; 7(3):460-7. PubMed ID: 18285702
[TBL] [Abstract][Full Text] [Related]
30. JAB1 regulates CPNE1-related differentiation via direct binding to CPNE1 in HiB5 hippocampal progenitor cells.
Yoo JC; Park N; Choi HY; Park JY; Yi GS
Biochem Biophys Res Commun; 2018 Feb; 497(1):424-429. PubMed ID: 29448099
[TBL] [Abstract][Full Text] [Related]
31. Expression of Jun activation domain-binding protein 1 and Ser10 phosphorylated p27 protein in human epithelial ovarian carcinoma.
Wang Y; Wang Y; Cheng C; Ji Y; Zhao Y; Zou L; Shen A
J Cancer Res Clin Oncol; 2009 Jul; 135(7):951-9. PubMed ID: 19139918
[TBL] [Abstract][Full Text] [Related]
32. Jab1, a novel protease-activated receptor-2 (PAR-2)-interacting protein, is involved in PAR-2-induced activation of activator protein-1.
Luo W; Wang Y; Hanck T; Stricker R; Reiser G
J Biol Chem; 2006 Mar; 281(12):7927-36. PubMed ID: 16410250
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia-inducible factor 1 promoter-induced JAB1 overexpression enhances chemotherapeutic sensitivity of lung cancer cell line A549 in an anoxic environment.
Hu MD; Xu JC; Fan Y; Xie QC; Li Q; Zhou CX; Mao M; Yang Y
Asian Pac J Cancer Prev; 2012; 13(5):2115-20. PubMed ID: 22901179
[TBL] [Abstract][Full Text] [Related]
34. Zinc-dependent interaction between JAB1 and pre-S2 mutant large surface antigen of hepatitis B virus and its implications for viral hepatocarcinogenesis.
Hsu JL; Chuang WJ; Su IJ; Gui WJ; Chang YY; Lee YP; Ai YL; Chuang DT; Huang W
J Virol; 2013 Dec; 87(23):12675-84. PubMed ID: 24049181
[TBL] [Abstract][Full Text] [Related]
35. The pivotal oncogenic role of Jab1/CSN5 and its therapeutic implications in human cancer.
Guo Z; Wang Y; Zhao Y; Shu Y; Liu Z; Zhou H; Wang H; Zhang W
Gene; 2019 Mar; 687():219-227. PubMed ID: 30468907
[TBL] [Abstract][Full Text] [Related]
36. Let-7d Inhibits Growth and Metastasis in Breast Cancer by Targeting Jab1/Cops5.
Wei Y; Liu G; Wu B; Yuan Y; Pan Y
Cell Physiol Biochem; 2018; 47(5):2126-2135. PubMed ID: 29975923
[TBL] [Abstract][Full Text] [Related]
37. Jab1 is overexpressed in human breast cancer and is a downstream target for HER-2/neu.
Hsu MC; Chai CY; Hou MF; Chang HC; Chen WT; Hung WC
Mod Pathol; 2008 May; 21(5):609-16. PubMed ID: 18246048
[TBL] [Abstract][Full Text] [Related]
38. Regulatory mechanisms and therapeutic potential of JAB1 in neurological development and disorders.
Yang Y; Song R; Gao Y; Yu H; Wang S
Mol Med; 2023 Jun; 29(1):80. PubMed ID: 37365502
[TBL] [Abstract][Full Text] [Related]
39. Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repair.
Tian L; Peng G; Parant JM; Leventaki V; Drakos E; Zhang Q; Parker-Thornburg J; Shackleford TJ; Dai H; Lin SY; Lozano G; Rassidakis GZ; Claret FX
Oncogene; 2010 Nov; 29(46):6125-37. PubMed ID: 20802511
[TBL] [Abstract][Full Text] [Related]
40. Jab1 is a specificity factor for E2F1-induced apoptosis.
Hallstrom TC; Nevins JR
Genes Dev; 2006 Mar; 20(5):613-23. PubMed ID: 16481464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
